Titan Pharmaceuticals Inc. Common Stock
Exchange: NASDAQ
Symbol: TTNP
SEC CIK: 0000910267
Phone: 6502444990
400 OYSTER POINT BLVD
SUITE 505
SAN FRANCISCO CA 94080
CEO:
|
Price when page updated: 0.345 Date: 2023-12-02
Company Website:
www.titanpharm.com
|
_Description: Titan Pharmaceuticals, Inc., based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
|
ADRTSO:
|
MarketCap:
5180622.00
|
Beta:
0.952694522976354
|
52 Week High:
4.61
|
52 Week Low:
1.03
|
52 Week Change:
-0.6419354838709677
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
9914158
|
Dividend Rate:
0
|
Dividend Yield:
4.87%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
N/A
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
N/A
|
ttmEPS:
-1.07
|
Revenue:
$247.626M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
0.70%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
2.59%
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
12.16
|
Price To Book:
2.06
|
Short Ratio:
0.96
|
PE Ratio:
-1.180636775024139
|
Employees:
12
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
__The following are links to various summary and news pages for
__Titan Pharmaceuticals Inc. Common Stock [ TTNP ].
__Note: Some Links might not have information for the company.
|
|
